Iloprost modulates the immune response in systemic sclerosis

被引：0
|
作者：
Patrizia D'Amelio
Maria A Cristofaro
Lucia D'Amico
Luciana Veneziano
Ilaria Roato
Francesca Sassi
Giuseppina Bisignano
Marta Saracco
Raffaele Pellerito
Salvatore Patanè
Riccardo Ferracini
Gian P Pescarmona
Giovanni C Isaia
机构：
[1] University of Torino,Gerontology Section, Department of Surgical and Medical Disciplines
[2] A.O.U. San Giovanni Battista,CeRMS (Center for Research and Medical Studies)
[3] Division of rheumatology "Ordine Mauriziano" Hospital,Department of Orthopaedics
[4] A.O.U. San Giovanni Battista,Department of Genetics
[5] Biology and Biochemistry - University of Torino,undefined
来源：
BMC Immunology | / 11卷
关键词：
Treg Cell; Connective Tissue Growth Factor; Iloprost; Critical Limb Ischemia; Skin Fibrosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Iloprost effects on phenotypic activation of circulating T cells in patients with systemic sclerosis
    Bellissimo, S
    Iannone, SF
    Covelli, M
    Lapadula, G
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 220 - 221
  • [42] ASSESSMENT OF PROSTANOIDS (ILOPROST, ALPROSTADIL) EFFICACY IN TREATMENT OF ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Starovoytova, M.
    Desinova, O.
    Koneva, O.
    Ovsyannikova, O.
    Garzanova, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1107 - 1108
  • [43] A case of diffuse systemic sclerosis treated with a 28-day infusion of iloprost
    Biasi, D
    Caramaschi, P
    Carletto, A
    Zeminian, S
    Schiavon, F
    Bambara, LM
    CLINICAL RHEUMATOLOGY, 1997, 16 (01) : 111 - 112
  • [44] Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al
    Braun, J
    Sieper, J
    Riemekasten, G
    Hiepe, F
    ARTHRITIS AND RHEUMATISM, 1999, 42 (01): : 196 - 197
  • [45] Treatment of ischaemic digital ulcers and prevention of gangrene with intravenous iloprost in systemic sclerosis
    Zachariae, H
    HalkierSorensen, L
    Bjerring, P
    Heickendorff, L
    ACTA DERMATO-VENEREOLOGICA, 1996, 76 (03) : 236 - 238
  • [46] Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost
    Caramaschi, Paola
    Dalla Gassa, Alessandra
    Prati, Daniele
    Barausse, Giovanni
    Tinazzi, Ilaria
    Ravagnani, Viviana
    Confente, Silvia
    Biasi, Domenico
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) : 1933 - 1938
  • [47] Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost
    Paola Caramaschi
    Alessandra Dalla Gassa
    Daniele Prati
    Giovanni Barausse
    Ilaria Tinazzi
    Viviana Ravagnani
    Silvia Confente
    Domenico Biasi
    Rheumatology International, 2012, 32 : 1933 - 1938
  • [48] ILOPROST (ILO) IN SYSTEMIC SCLEROSIS (SSC): THE SAFETY EXPERIENCE OF TWO ITALIAN CENTRES
    Guiducci, S.
    Bellando-Randone, S.
    Bruni, C.
    Giuggioli, D.
    Colaci, M.
    Lumetti, F.
    Lepri, G.
    Fiori, G.
    Bartoli, F.
    Ferri, C.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1122 - 1122
  • [49] Pharmacokinetics of oral iloprost in patients with Raynaud's phenomenon secondary to systemic sclerosis
    Janssen, MCH
    Wollersheim, H
    Kraus, C
    Hildebrand, M
    Watson, HR
    Thien, T
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 60 (4-6): : 153 - 160
  • [50] IMMUNE RESPONSE GENE 1 (IRG1) IS DYSREGULATED IN SYSTEMIC SCLEROSIS
    O'Reilly, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1194 - 1194
12345